Bangladesh begins immunisation against anthrax

	Tweet

Bangladesh launched an immunisation drive on Sunday against anthrax in a southeastern region after a wild elephant died of the disease and triggered a scare that more might be infected.

Veterinarians on Friday said anthrax, which can be fatal to humans and farm animals and is highly infectious, had killed the elephant near Bandarban hill town, 350 km (219 miles) from the capital Dhaka.

"We have started immunising domestic and forest animals and have asked people to remain alert,” environment and forests minister Tariqul Islam told Reuters.

“Adequate animal vaccines have been sent to Bandarban for injecting domestic animals as precaution,” the minister added.

No domestic animal had been reported to have been infected, Tariqul said.

Veterinarians feared the disease could have infected more elephants and other wild species in the remote 14,200 sq km (5,500 sq mile) Chittagong Hill Tracts that border India and Myanmar.

The area is home to 400 wild elephants, including 100 believed to have migrated from across both borders. 

RELATED STORIES:
Childhood viral infection may be a cause of obesity   Health workers often decline TB treatment   Finding Better Ways to Treat Tropical Disease Caused by Parasitic Worm   Drug-resistance fears for deadly fungal disease   Pneumonia can be treated effectively in nursing homes   No prion diseases found in German deer   Study Uncovers How Tuberculosis Agent Survives on Fatty Acids   Study finds dangerous bacteria on cell phones of hospital patients   Vaccine cuts meningitis rates, even in adults   New treatment for brucellosis   Pneumonic plague in the Congo   New discovery boosts basic understanding of prion infections

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]